Intratumoral disulfidptosis heterogeneity in triple-negative breast cancer, a multiomics integration analysis
Authors:
Open Access
- 1 October 2025
- journal article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (10) , 6653-6666
Abstract
Background: Triple-negative breast cancer (TNBC) is characterized by heterogeneity and metabolic reprogramming. Disulfidptosis represents a new category of regulated cell death that is mediated by cystine and cysteine metabolism. However, the underlying mechanism related to the heterogeneity of TNBC disulfidptosis remains unclear. In this study, we aimed to analyze whether disulfidptosis exhibits heterogeneity in TNBC. Methods: Initial molecular subtyping was performed via K-means clustering. Subsequent subtype characterization included enrichment analysis, differential activity score (DA score) analysis, and in vitro drug sensitivity assays targeting disulfidptosis pathways. The prognostic model was derived through univariate Cox regression followed by least absolute shrinkage and selection operator (LASSO) regression of disulfidptosis-associated genes and metabolites. The prediction model was graphically displayed as a nomogram. Results: Through bioinformatics analysis of a TNBC multiomic dataset (n=465), we divided TNBCs into two disulfidptosis-related subtypes: cluster 1 and cluster 2. Compared with cluster 2, cluster 1 had an activated pentose phosphate pathway, an immunosuppressive microenvironment and a poor prognosis. We further confirmed that TNBC cell lines in cluster 1 were more sensitive to disulfidptosis induced by glucose deprivation or the inhibition of GLUT1. Moreover, the disulfidptosis-associated genes and metabolites-based predictive model demonstrated robust predictive performance. Conclusions: Taken together, our research demonstrated the heterogeneity of TNBC disulfidptosis and presented a promising treatment strategy for targeting disulfidptosis in TNBC.Keywords
This publication has 30 references indexed in Scilit:
- Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment StrategiesCancer Cell, 2019
- Redox control in cancer development and progressionMolecular Aspects of Medicine, 2018
- Time-dependent ROC curve analysis in medical research: current methods and applicationsBMC Medical Research Methodology, 2017
- An Integrated Metabolic Atlas of Clear Cell Renal Cell CarcinomaCancer Cell, 2016
- The Tumorigenic Roles of the Cellular REDOX Regulatory SystemsOxidative Medicine and Cellular Longevity, 2015
- Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapyGenome Biology, 2015
- Robust enumeration of cell subsets from tissue expression profilesNature Methods, 2015
- Triple-negative breast cancer: epidemiological considerations and recommendationsAnnals of Oncology, 2012
- Cellular Redox Pathways as a Therapeutic Target in the Treatment of CancerDrugs, 2011
- Regularization Paths for Generalized Linear Models via Coordinate Descent2010